Bacchus Vascular, Inc. · Santa Clara, CA United States
Company Description
View Bacchus Vascular, Inc. Locations On A US Map
This link will open in a new window
Bacchus Vascular lets the good times keep flowing. The company makes the Trellis infusion system, which treats deep vein thrombosis and other clotting disorders. Where typical medication treatments used alone are effective in preventing further clots, they do not always remove clots. The Trellis system is designed to permanently dissolve blood clots in one quickly administered catheter-based procedure. Currently, the system is designed to treat only deep vein thrombosis, but the company is looking into how it can be used to treat other vascular disorders. The company is also focused on making its system an industry standard. Bacchus Vascular was acquired by health care equipment maker Covidien in 2009. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key Bacchus Vascular, Inc. Financials
| Company Type | Subsidiary Single Location |
| Fiscal Year-End | December |
| Annual Sales (mil.) | $0.1 |
| Employees | 27 |
Bacchus Vascular, Inc. Executives
10 executives listed for Bacchus Vascular, Inc.'s Santa Clara, CA location.
| Title | Name & Bio | Contact |
| President, CEO, and Director | Scott Cramer | Network |
| VP Operations | Ali Shirazi | Network |
| Director Finance | Kevin Brown | Network |
Competition
Competitive Landscape for Bacchus Vascular, Inc.
Demand is driven by population demographics and advances in medical knowledge and technology. The profitability of individual companies depends on the ability to develop superior products. Large companies have economies of scale in manufacturing and R&D. Small companies can compete successfully by specializing in a particular market segment, or through technical innovation. To read the full description, subscribe now.Top Bacchus Vascular, Inc. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
